FFF Enterprises, Inc., recognized as the nation’s most trusted specialty drug distributor and diversified healthcare company, ...

Recursion Pharmaceuticals is now the sole owner of a drug in its pipeline. The deal de-risks the company's pipeline by ...

The country’s manufacturing output grew at a faster rate in May due mainly to increases in the production of food and ...

Shares of Recursion Pharmaceuticals climbed after the company said it has agreed to purchase Rallybio's interest in a drug-development plan that aims to treat a rare genetic bone disease. The stock ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company"), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform ...

Trump’s “big beautiful” bill will also affect the pharmaceutical industry, while AI startups have pulled in the majority of ...

The company has successfully completed seven export-sourcing assignments concluded during Q1 FY 2025-26 worth Rs 299.91 crore ...

Switzerland’s medical products authority has granted the first approval for a malaria medicine designed for small infants, touted as a breakthrough against a disease that takes ...

Mumbai-based Ananta Capital, an investment firm that is anchored by the family office of the Taparia Group that ...

There are several successful investing strategies in the stock market and one of them is Dogs of the Dow. It is a strategy ...

Robbins Geller files suit against Rocket Pharma over undisclosed trial risks tied to RP-A501. Lead plaintiff deadline: August ...

Drugmaker Sai Parenterals, analytics startup Linkrunner, and software-as-a-service (SaaS) platform Monetize360 have ...